Literature DB >> 14171789

EFFECT OF DOPAMINE IN MAN: AUGMENTATION OF SODIUM EXCRETION, GLOMERULAR FILTRATION RATE, AND RENAL PLASMA FLOW.

R H MCDONALD, L I GOLDBERG, J L MCNAY, E P TUTTLE.   

Abstract

Entities:  

Keywords:  BLOOD CIRCULATION; DOPAMINE; HEART FAILURE, CONGESTIVE; KIDNEY; NATRIURESIS; NOREPINEPHRINE; PHARMACOLOGY; PHYSIOLOGY; SYMPATHOMIMETICS; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1964        PMID： 14171789      PMCID： PMC289593          DOI： 10.1172/JCI104996

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  27 in total

1.  Peripheral vascular effects of noradrenaline, isopropylnoradrenaline and dopamine.

Authors:  M J ALLWOOD; A F COBBOLD; J GINSBURG
Journal:  Br Med Bull       Date:  1963-05       Impact factor: 4.291

2.  The occurrence, distribution and physiological role of catecholamines in the nervous system.

Authors:  A CARLSSON
Journal:  Pharmacol Rev       Date:  1959-06       Impact factor: 25.468

3.  The development of current concepts of catecholamine formation.

Authors:  H BLASCHKO
Journal:  Pharmacol Rev       Date:  1959-06       Impact factor: 25.468

4.  Cardiovascular effects of isoproterenol in normal subjects and subjects with congestive heart failure.

Authors:  H T DODGE; J D LORD; H SANDLER
Journal:  Am Heart J       Date:  1960-07       Impact factor: 4.749

5.  The cardiovascular and renal hemodynamic effects of aramine.

Authors:  W R LIVESAY; J H MOYER; D W CHAPMAN
Journal:  Am Heart J       Date:  1954-05       Impact factor: 4.749

6.  HEMODYNAMIC ALTERATIONS IN NORMOTENSIVE AND HYPERTENSIVE SUBJECTS DURING THE PYROGENIC REACTION.

Authors:  S E Bradley; H Chasis; W Goldring; H W Smith
Journal:  J Clin Invest       Date:  1945-09       Impact factor: 14.808

7.  The effect of theophylline ethylene diamine on renal function in control subjects and in patients with congestive heart failure.

Authors:  J O DAVIS; N W SHOCK
Journal:  J Clin Invest       Date:  1949-11       Impact factor: 14.808

8.  The variability of measurement of insulin and diodrast tests of kidney function.

Authors:  D F DAVIES; N W SHOCK
Journal:  J Clin Invest       Date:  1950-05       Impact factor: 14.808

9.  The ineffectiveness of an inotropic agent, mephentermine (Wyamine), in the treatment of congestive heart failure.

Authors:  R L FRYE; R L KAHLER; E BRAUNWALD
Journal:  Am Heart J       Date:  1961-09       Impact factor: 4.749

10.  The depressor action of dopamine and adrenaline.

Authors:  J H BURN; M J RAND
Journal:  Br J Pharmacol Chemother       Date:  1958-12
View more
  97 in total

Review 1.  Can the use of low-dose dopamine for treatment of acute renal failure be justified?

Authors:  C J Burton; C R Tomson
Journal:  Postgrad Med J       Date:  1999-05       Impact factor: 2.401

2.  The effect of dopamine on glomerular filtration rate in normotensive, oliguric premature neonates.

Authors:  Susan K Lynch; Kevin V Lemley; Mark J Polak
Journal:  Pediatr Nephrol       Date:  2003-05-16       Impact factor: 3.714

3.  VASOACTIVE DRUG TESTING IN CALVES FOLLOWING TOTAL ARTIFICIAL HEART IMPLANTATION.

Authors:  Yoshitsugu Kito; Isao Nagai; Takehiko Honda; W Harry Gibson; Tetsuzo Akutsu
Journal:  Cardiovasc Dis       Date:  1975

4.  The effects of dopamine and a low protein diet on glomerular filtration rate and renal plasma flow in the aged kidney.

Authors:  G J Fancourt; V S Asokan; S C Bennett; J Walls; C M Castleden
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

5.  Haemodynamic effects of a new inotropic agent (dobutamine) in chronic cardiac failure.

Authors:  J Beregovich; C Bianchi; R D'Angelo; R Diaz; S Rubler
Journal:  Br Heart J       Date:  1975-06

6.  Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors.

Authors:  R A Brown; J Dixon; J B Farmer; J C Hall; R G Humphries; F Ince; S E O'Connor; W T Simpson; G W Smith
Journal:  Br J Pharmacol       Date:  1985-07       Impact factor: 8.739

7.  Studies with fenoldopam, a dopamine receptor DA1 agonist, in essential hypertension.

Authors:  J N Harvey; D P Worth; J Brown; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1986-01       Impact factor: 4.335

8.  Renal blood-flow changes during renal nerve stimulation in rats treated with alpha-adrenergic and dopaminergic blockers.

Authors:  B J Chapman; N M Horn; M J Robertson
Journal:  J Physiol       Date:  1982-04       Impact factor: 5.182

9.  Renal effects of xamoterol in patients with moderate heart failure.

Authors:  H E Bøtker; H K Jensen; L R Krusell; E V Sørensen
Journal:  Cardiovasc Drugs Ther       Date:  1993-02       Impact factor: 3.727

10.  Chronic regulation of the renal Na(+)/H(+) exchanger NHE3 by dopamine: translational and posttranslational mechanisms.

Authors:  Ming Chang Hu; Francesca Di Sole; Jianning Zhang; Paul McLeroy; Orson W Moe
Journal:  Am J Physiol Renal Physiol       Date:  2013-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.